| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/29/2004 | US20040082635 Fused cyclic compounds and medicinal use thereof |
| 04/29/2004 | US20040082631 Pyrazole compositions useful as inhibitors of ERK |
| 04/29/2004 | US20040082626 Cyclic compounds exhibiting thrombopoietin receptor agonism |
| 04/29/2004 | US20040082622 N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |
| 04/29/2004 | US20040082620 Antidiabetic agents |
| 04/29/2004 | US20040082619 Pyridone derivatives having affinity for cannabinoid 2-type receptor |
| 04/29/2004 | US20040082611 Novel sulfonyl derivatives |
| 04/29/2004 | US20040082609 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 04/29/2004 | US20040082607 Fused heterocyclic compounds |
| 04/29/2004 | US20040082605 Use |
| 04/29/2004 | US20040082604 Antiarthritic agents; osteoporosis; immunosuppressants; antiinflammatory agents; autoimmunology diseases |
| 04/29/2004 | US20040082597 Use of CRF antagonists and related compositions |
| 04/29/2004 | US20040082595 Antiproliferative agents; antitumor agents; cyclin-dependent kinase inhibitor |
| 04/29/2004 | US20040082592 Metabotropic glutamate receptor antagonists |
| 04/29/2004 | US20040082591 Psychological disorders; antidepressants; anxiolytic agents; eating disorders; sleep disorders; gastrointestinal disorders; cardiovascular disorders |
| 04/29/2004 | US20040082590 Dietetics; antidiabetic agents; sexual disorders |
| 04/29/2004 | US20040082583 Chemical compounds |
| 04/29/2004 | US20040082576 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/29/2004 | US20040082575 Compounds and methods for modulation of estrogen receptors |
| 04/29/2004 | US20040082573 Anxiolytic agents with reduced sedative and ataxic effects |
| 04/29/2004 | US20040082572 Benzodiazepine derivatives as app modulators |
| 04/29/2004 | US20040082564 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 04/29/2004 | US20040082562 Novel inhibitors of IMPDH enzyme |
| 04/29/2004 | US20040082559 Vitronectin receptor antagonists |
| 04/29/2004 | US20040082553 Novel florfenicol-type antibiotics |
| 04/29/2004 | US20040082497 For treatment of growth hormone deficiency/polycystic ovary syndrome autoimmune/inflammatory disease |
| 04/29/2004 | US20040082041 Rhodotorula |
| 04/29/2004 | CA2501547A1 Substituted indoles and their use as hcv inhibitors |
| 04/29/2004 | CA2501539A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
| 04/29/2004 | CA2500320A1 Novel compounds with antibacterial activity |
| 04/29/2004 | CA2500083A1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 04/29/2004 | CA2496633A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 04/28/2004 | EP1413306A1 Tetrahydroquinoline derivatives as CRTH2 antagonists |
| 04/28/2004 | EP1413199A1 An agricultural and horticultural disease controller and a method for controlling the diseases |
| 04/28/2004 | EP1412364A1 Platelet adp receptor inhibitors |
| 04/28/2004 | EP1412349A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists |
| 04/28/2004 | EP1412338A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1412028A1 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 04/28/2004 | EP1411942A1 Substituted anilinic piperidines as mch selective antagonists |
| 04/28/2004 | EP1411933A1 Alpha-ketoamide derivatives as cathepsin k inhibitors |
| 04/28/2004 | EP1411932A1 Substituted oxazolidinones for combinational therapy |
| 04/28/2004 | EP1411929A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/28/2004 | EP1411928A1 Viral polymerase inhibitors |
| 04/28/2004 | EP1244642B1 Substituted oxazoles and thiazoles derivatives as hppar alpha activators |
| 04/28/2004 | EP1228062B1 Herbicidal 2-aryloxy-6-fluoroalkylthioalk(en)yloxy-pyridines |
| 04/28/2004 | EP1208096B1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
| 04/28/2004 | EP1150962B1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds from carbamate compounds |
| 04/28/2004 | EP1135124B1 Antihypertriglyceridemic, antihyperglycemic, anti-angiogenic and wound healing substituded indolealkanoic acids |
| 04/28/2004 | EP1042313B1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity |
| 04/28/2004 | CN1492867A Novel thioes derivatives of thiazolyl acetic acid and their use in preparation of cephalosporin compounds |
| 04/28/2004 | CN1492856A Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 04/28/2004 | CN1492762A Azoles as malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 04/28/2004 | CN1491949A Pyridazine-3-one derivatives, their use, and intermediate preparing them |
| 04/27/2004 | US6727364 Antiinflammatory agents |
| 04/27/2004 | US6727276 Epothilone derivatives for the treatment of refractory tumors |
| 04/27/2004 | US6727271 Oxazole or thiazole derivatives; antilipemic agents, hypotensives, antineoplastic agents |
| 04/27/2004 | US6727270 Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands |
| 04/27/2004 | US6727269 Acromegaly, pituitary adenoma or endocrine gastroenteropanceatic tumors including the carcinoid syndrome, and gastrointestinal bleeding |
| 04/27/2004 | US6727267 NS5B HVC polymerase inhibitors |
| 04/27/2004 | US6727264 Substituted anilinic piperidines as MCH selective antagonists |
| 04/27/2004 | US6727256 4-aminoquinazoline derivatives as anticarcinogenic agents |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | US6727248 Substituted quinolinecarboxamides as antiviral agents |
| 04/27/2004 | US6727247 Adenosine receptor ligands in a method of treatment, control, or prevention of central nervous system disorders |
| 04/27/2004 | US6727053 Forms an azomethine dye upon a coupling reaction with an oxidized product of a developing agent |
| 04/27/2004 | US6727041 Optical recording media |
| 04/27/2004 | CA2136745C Heterocyclically disubstituted sulphonylamino(thio)carbonyl compounds |
| 04/22/2004 | WO2004033652A2 Inhibitors of fatty acid amide hydrolase |
| 04/22/2004 | WO2004033632A2 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace) |
| 04/22/2004 | WO2004033452A1 Thiadiazole compound and use thereof |
| 04/22/2004 | WO2004033451A1 Antimicrobial [3.1.0] bicyclic oxazolidinone derivatives |
| 04/22/2004 | WO2004033440A1 Thiadiazoledioxides and thiadiazoleoxides as cxc- and cc-chemokine receptor ligands |
| 04/22/2004 | WO2004033439A1 Thiazole compounds for the treatment of neurodegenerative disorders |
| 04/22/2004 | WO2004033432A1 Novel pyrazole compounds having antifungal activity |
| 04/22/2004 | WO2004033428A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 04/22/2004 | WO2004033427A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
| 04/22/2004 | WO2004033418A2 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists |
| 04/22/2004 | WO2004032929A2 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer’s disease |
| 04/22/2004 | WO2004032882A2 Chemical compounds |
| 04/22/2004 | WO2004032848A2 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 04/22/2004 | WO2004032846A2 Triazolone and triazolethione derivatives |
| 04/22/2004 | WO2004032834A2 Thrombin inhibitors |
| 04/22/2004 | WO2004014852A3 Iminothiazolidinones as inhibitors of hcv replication |
| 04/22/2004 | WO2004010945A3 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 04/22/2004 | WO2002074767A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074752A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074748A8 Metalloproteinase inhibitors |
| 04/22/2004 | US20040077877 Jun n-terminal kinase inhibitors |
| 04/22/2004 | US20040077875 (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2 -thiazolyl)carbamic Acid, 1,1-dimethylethyl ester for example; treating immunological and oncological disorders such as inflammatory bowel disease or cancer |
| 04/22/2004 | US20040077699 Substituted triazole diamine derivatives as kinase inhibitors |
| 04/22/2004 | US20040077697 2-Acylaminothiazole derivative or its salt |
| 04/22/2004 | US20040077696 Heterocyclic inhibitors of kinases |
| 04/22/2004 | US20040077695 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 04/22/2004 | US20040077689 Abc expression promoters |
| 04/22/2004 | US20040077687 Thiazolmines and their use as tgf-beta inhibitors |
| 04/22/2004 | US20040077671 Sorbitol dehydrogenase inhibitors |
| 04/22/2004 | US20040077670 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/22/2004 | US20040077667 Quinazolinone derivatives |
| 04/22/2004 | US20040077655 Piperazine derivatives for treatment of bacterial infections |
| 04/22/2004 | US20040077654 Anticholesterol agents; cardiovascular disorders |